The mechanism of action of diazoxide is by blocking sulfonylurea receptor 1 subunit of KATP-channel on pancreatic beta (ẞ) cells, which increases the permeability to potassium ions, resulting in hyperpolarization of the cells. Hyperpolarization of the ẞ-cells inhibits calcium-dependent insulin secretion.